Duloxetine + Sugar pill
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Osteoarthritis
Conditions
Osteoarthritis
Trial Timeline
Mar 1, 2012 → Aug 1, 2014
NCT ID
NCT01558700About Duloxetine + Sugar pill
Duloxetine + Sugar pill is a approved stage product being developed by Eli Lilly for Osteoarthritis. The current trial status is completed. This product is registered under clinical trial identifier NCT01558700. Target conditions include Osteoarthritis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01558700 | Approved | Completed |
| NCT01223001 | Phase 2 | Terminated |
Competing Products
20 competing products in Osteoarthritis